239 related articles for article (PubMed ID: 19746787)
1. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
[TBL] [Abstract][Full Text] [Related]
2. Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.
Kehwar TS; Jones HA; Huq MS; Smith RP
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):621-7. PubMed ID: 20932692
[TBL] [Abstract][Full Text] [Related]
3. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
Chen Z; Deng J; Roberts K; Nath R
Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
[TBL] [Abstract][Full Text] [Related]
4. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
5. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
6. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
[TBL] [Abstract][Full Text] [Related]
7. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
8. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
Crook J; McLean M; Yeung I; Williams T; Lockwood G
Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
[TBL] [Abstract][Full Text] [Related]
9. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
10. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
[TBL] [Abstract][Full Text] [Related]
11. Prescription dose in permanent (131)Cs seed prostate implants.
Yue N; Heron DE; Komanduri K; Huq MS
Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
[TBL] [Abstract][Full Text] [Related]
12. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
13. Effect of prostatic edema on CT-based postimplant dosimetry.
Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
[TBL] [Abstract][Full Text] [Related]
14. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Uno H; Ohtakara K; Miyoshi T; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):614-8. PubMed ID: 17869675
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
16. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
Chung E; Stenmark MH; Evans C; Narayana V; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1944-8. PubMed ID: 21640498
[TBL] [Abstract][Full Text] [Related]
17. Examining the relationship between pre- and postimplant geometry in prostate low-dose-rate brachytherapy and its correlation with dosimetric quality using the similarity concept.
Todor DA; Anscher MS; Karlin JD; Hagan MP
Brachytherapy; 2014; 13(5):471-80. PubMed ID: 25037911
[TBL] [Abstract][Full Text] [Related]
18. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):610-21. PubMed ID: 12062604
[TBL] [Abstract][Full Text] [Related]
19. The impact of postimplant edema on the urethral dose in prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):661-4. PubMed ID: 10837949
[TBL] [Abstract][Full Text] [Related]
20. The impact of edema on planning 125I and 103Pd prostate implants.
Yue N; Dicker AP; Nath R; Waterman FM
Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]